Jump to content

WHO asks for Ebola anti-body from Bangkok's Siriraj for lab test


webfact

Recommended Posts

WHO asks for Ebola anti-body from Siriraj for lab test

BANGKOK: -- The World Health Organisation has requested for a sample of therapeutic antibody for Ebola virus from Siriraj Hospital, clinical Prof Dr Udom Kachintorn, dean of Mahidol University's Faculty of Medicine Siriraj Hospital, said Friday.


He said the WHO wanted to try applying the anti-body with the real Ebola in its Bio-safety Level 4 laboratory in the United States.

He said if the anti-body works effectively, WHO may develop it as a cure for the the deadly Ebola Haemorrhagic Fever, and thus cutting the process of trials in the animals and human beings.

Source: http://www.nationmultimedia.com/breakingnews/WHO-asks-for-Ebola-anti-body-from-Siriraj-for-lab--30244693.html

nationlogo.jpg
-- The Nation 2014-10-03

  • Like 1
Link to comment
Share on other sites

  • Replies 80
  • Created
  • Last Reply

Top Posters In This Topic

From WHO website...

Two promising candidate vaccines

Given the public health need for safe and effective Ebola interventions, WHO regards the expedited evaluation of all Ebola vaccines with clinical grade material as a high priority.

Two candidate vaccines have clinical-grade vials available for phase 1 pre-licensure clinical trials.

One (cAd3-ZEBOV) has been developed by GlaxoSmithKline in collaboration with the US National Institute of Allergy and Infectious Diseases. It uses a chimpanzee-derived adenovirus vector with an Ebola virus gene inserted.

The second (rVSV-ZEBOV) was developed by the Public Health Agency of Canada in Winnipeg. The license for commercialization of the Canadian vaccine is held by an American company, the NewLink Genetics company, located in Ames, Iowa. The vaccine uses an attenuated or weakened vesicular stomatitis virus, a pathogen found in livestock; one of its genes has been replaced by an Ebola virus gene.

  • Like 2
Link to comment
Share on other sites

From WHO website...

Two promising candidate vaccines

Given the public health need for safe and effective Ebola interventions, WHO regards the expedited evaluation of all Ebola vaccines with clinical grade material as a high priority.

Two candidate vaccines have clinical-grade vials available for phase 1 pre-licensure clinical trials.

One (cAd3-ZEBOV) has been developed by GlaxoSmithKline in collaboration with the US National Institute of Allergy and Infectious Diseases. It uses a chimpanzee-derived adenovirus vector with an Ebola virus gene inserted.

The second (rVSV-ZEBOV) was developed by the Public Health Agency of Canada in Winnipeg. The license for commercialization of the Canadian vaccine is held by an American company, the NewLink Genetics company, located in Ames, Iowa. The vaccine uses an attenuated or weakened vesicular stomatitis virus, a pathogen found in livestock; one of its genes has been replaced by an Ebola virus gene.

The Nation is reporting lies?????

  • Like 1
Link to comment
Share on other sites

Even if the thai treatment is effective there remains much to be seen, such as degree of effectiveness. Also by their own definition the drug will most definitely not cure ebola but help patients to suvive the disease by limiting the hemorrhage component. Yet another misnomer from a faculty that should know better.

http://www.washingtonpost.com/news/to-your-health/wp/2014/10/02/a-liberian-doctor-is-using-hiv-drugs-to-treat-ebola-victims-the-nih-is-intrigued/

in the meanwhile, one liberian doctor overwhelmed caring for ebola patients reasoned that a certain HIV drug works by lowering rna virus replication in the body. with nothing left to lose he gave it to 15 patients. 13/15 survivrd.

quite a clever guy without a teaching university or laboratory.

Gorbee Logan, a doctor in rural Liberia, has given at least 15 Ebola patients lamivudine, which is considered a long-term and effective drug to treat HIV patients. All but two of them survived, Logan told CNN last week.

  • Like 2
Link to comment
Share on other sites

Siriraj Hospital has a bio-safety level 3 facility which has been adequate for its research on HIV, SARS, H5N1, H1N1, etc. but not for Ebola. So it is unlikely that the alleged Ebola anti-body was developed from nor tested on live (aka "real") Ebola virus.

Link to comment
Share on other sites

From WHO website...

Two promising candidate vaccines

Given the public health need for safe and effective Ebola interventions, WHO regards the expedited evaluation of all Ebola vaccines with clinical grade material as a high priority.

Two candidate vaccines have clinical-grade vials available for phase 1 pre-licensure clinical trials.

One (cAd3-ZEBOV) has been developed by GlaxoSmithKline in collaboration with the US National Institute of Allergy and Infectious Diseases. It uses a chimpanzee-derived adenovirus vector with an Ebola virus gene inserted.

The second (rVSV-ZEBOV) was developed by the Public Health Agency of Canada in Winnipeg. The license for commercialization of the Canadian vaccine is held by an American company, the NewLink Genetics company, located in Ames, Iowa. The vaccine uses an attenuated or weakened vesicular stomatitis virus, a pathogen found in livestock; one of its genes has been replaced by an Ebola virus gene.

The Nation is reporting lies?????

No but some people tend to tell white lies to get media attention.

Link to comment
Share on other sites

It is also unlikely that a real Ebola virus was imported into Thailand for study.

Especially considering there is nowhere safe enough to store it. Let alone transport it.

And can you imagine any gov. cabinet being asked to OK importing it for study?

So how did they have more than a computer simulation of Ebola to design an anti-body for it?

And why do they believe a computer simulation and then some genetic tinkering may have designed a cure?

And of course having designed an anti-body, does not equal their statement of having ;

'Created a cure for Ebola.'

WHO is calling their bluff, and partly wishful thinking that they might accidentally have something useful.

I hope they have...

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.








×
×
  • Create New...